These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3970558)

  • 1. [Effect of OK-432 on activated lysozyme in monocytes and neutrophils --comparison of intravenous and intramuscular administrations].
    Fujii M; Okabe K; Tamai M; Toki H
    Gan To Kagaku Ryoho; 1985 Feb; 12(2):383-4. PubMed ID: 3970558
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of intravenous treatment with OK-432 on the bone marrow in patients with lung cancer].
    Fujii M; Ishikawa M; Toki H
    Gan No Rinsho; 1984 Mar; 30(3):230-2. PubMed ID: 6325756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Enhancing effects on interferon-gamma production by combination of OK-432 and interferon-alpha in patients with head and neck cancer].
    Sugiyama M; Morisaki N; Konishi K; Go K; Sugita M; Nakai Y
    Gan To Kagaku Ryoho; 1984 Oct; 11(10):2200-6. PubMed ID: 6435540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hemodynamic effects of a large dose injection of OK-432 (picibanil)].
    Morita K; Murata T; Marumoto M; Tsuboi H; Nakahara Y; Oda T; Mohri H
    Nihon Geka Gakkai Zasshi; 1983 Apr; 84(4):295-300. PubMed ID: 6674797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antitumor activity of neutrophils induced by a nonspecific immunopotentiator OK-432. III. Experimental study using human peripheral neutrophils].
    Umemoto T; Saji S; Enami H; Kunii Y; Goshima H; Tachibana S; Takao H; Sakata K
    Nihon Gan Chiryo Gakkai Shi; 1988 Jul; 23(7):1518-24. PubMed ID: 3183460
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of immunopotentiating agents (BCG, picibanil, and levamisole) and Maruyama vaccine on neutrophil functions including the generation of oxygen intermediates].
    Niwa Y; Maeda M
    Arerugi; 1983 Feb; 32(2):61-71. PubMed ID: 6615239
    [No Abstract]   [Full Text] [Related]  

  • 7. [Synergistic activation of rat alveolar macrophages by cepharanthine and OK-432].
    Morioka S; Ono M; Tanaka N; Orita K
    Gan To Kagaku Ryoho; 1985 Jul; 12(7):1470-5. PubMed ID: 4015121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Organ distribution of 99m technetium-labeled OK-432 following intravenous administration in man].
    Toki H; Ishikawa M; Fujii M; Yumoto Y; Ishimitsu T
    Gan To Kagaku Ryoho; 1982 Dec; 9(12):2201-6. PubMed ID: 7184393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunocytochemical localization of myeloperoxidase, lactoferrin, lysozyme and neutral proteases in human monocytes and neutrophilic granulocytes.
    Pryzwansky KB; Martin LE; Spitznagel JK
    J Reticuloendothel Soc; 1978 Sep; 24(3):295-310. PubMed ID: 83363
    [No Abstract]   [Full Text] [Related]  

  • 10. [Basic studies on the effects of oral administration of streptococcal preparation OK-432. I. Effects of thoracic duct lymphocytes].
    Hanaue H; Kurosawa T; Nemoto A; Asagoe T; Shikata J
    Nihon Gan Chiryo Gakkai Shi; 1987 Aug; 22(7):1348-53. PubMed ID: 3501454
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of streptococcal preparation OK-432 on chemically-induced intestinal carcinoma in rats.
    Ichihashi H; Kuzuya H; Kondo T
    Nagoya J Med Sci; 1980 Mar; 42(3-4):49-54. PubMed ID: 7383144
    [No Abstract]   [Full Text] [Related]  

  • 12. [Influence of OK-432 on the concentration of active substance of fluoropyrimidine carcinostatics in the living body].
    Okamoto Y; Nakamura A; Ohkawa T
    Nihon Gan Chiryo Gakkai Shi; 1986 May; 21(4):780-5. PubMed ID: 3093612
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of biological response modifier-streptococcal preparation OK-432 on NK/K cell system of gnotobiotic miniature swine.
    Kim YB
    Prog Clin Biol Res; 1985; 181():337-41. PubMed ID: 4063011
    [No Abstract]   [Full Text] [Related]  

  • 14. [Activation of macrophage function by OK-432 and its subcellular fractions].
    Yamamoto Y; Kawakami K; Sakata A; Onoue K
    Gan To Kagaku Ryoho; 1987 Apr; 14(4):1169-71. PubMed ID: 3032115
    [No Abstract]   [Full Text] [Related]  

  • 15. [NK activities in cancer patients--their modification by an immunopotentiator].
    Sasanami T; Fujishima A; Moriya Y; Imai K; Yachi A
    Gan To Kagaku Ryoho; 1982 Dec; 9(12):2186-92. PubMed ID: 7184392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does OK-432 selectively increase bleomycin concentration in tumor?
    Okuyama S; Mishina H; Matsuzawa T
    Gan; 1979 Jun; 70(3):385-6. PubMed ID: 89059
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of pyrogenal on blood lysozyme activity in rabbits].
    Zabirov ISh; Ausheva LKh
    Antibiotiki; 1974 Nov; 19(11):1003-6. PubMed ID: 4218471
    [No Abstract]   [Full Text] [Related]  

  • 18. Blood monocytes--lysozyme (muramidase) activity and IgG receptor.
    Ota H
    Nihon Ketsueki Gakkai Zasshi; 1973 Oct; 36(5):765-84. PubMed ID: 4604169
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of immunological responses and survival periods in cancer patients treated with intradermal and intramuscular injection of the streptococcal preparation OK-432.
    Hanaue H; Kurosawa T; Yasuda H; Yoshizaki S; Nomoto SN; Takada T; Shikata J
    Keio J Med; 1984 Apr; 33(1):17-27. PubMed ID: 6482140
    [No Abstract]   [Full Text] [Related]  

  • 20. Activation of the complement by immunostimulants, BCG, OK-432 (Picibanil), and PS-K (Krestin) in vitro.
    Kondo M; Kato H; Yokoe N; Matsumura N; Hotta T; Masuda M
    Gan; 1978 Oct; 69(5):699-702. PubMed ID: 729967
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.